Skip to main content
logo
AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
14.85
-0.15 (-1.00%)
At close: Aug 11, 2026, 4:00 PM EDT
14.85
0.00 (0.00%)
After-hours: Aug 11, 2026, 4:10 PM EDT

AgomAb Therapeutics NV Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
221.5986.42171.46
Short-Term Investments
30.3930.1-
Cash & Short-Term Investments
251.98116.51171.46
Cash Growth
46.96%-32.05%-
Other Current Assets
6.54.722.39
Total Current Assets
258.48121.24173.85
Net Property, Plant & Equipment
1.411.591.99
Other Intangible Assets
20.1120.1120.11
Goodwill
8.618.618.61
Long-Term Investments
0.010.010.01
Other Long-Term Assets
2.32.151.79
Total Assets
290.92153.71206.36

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
11.8410.278.05
Accrued Expenses
1.261.550.8
Current Portion of Leases
0.230.250.27
Other Current Liabilities
6.746.53-
Total Current Liabilities
20.0718.599.13
Long-Term Leases
0.911.011.27
Other Long-Term Liabilities
4.573.217.88
Total Long-Term Liabilities
5.484.229.15
Total Liabilities
25.5522.818.28

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Common Stock
304.62223.07223.07
Additional Paid-in Capital
187.7390.5185.16
Accumulated Other Comprehensive Income
-14.36-0.97-0.97
Retained Earnings
-212.62-181.71-119.18
Shareholders' Equity
265.38130.9188.08
Total Liabilities & Equity
290.92153.71206.36

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
1.141.251.55
Net Cash (Debt)
250.84115.26169.91
Net Cash Growth
47.63%-32.17%-
Net Cash Per Share
12.15213.00314.00
Book Value
265.38130.9188.08
Book Value Per Share
12.85241.91347.57
Tangible Book Value
236.65102.18159.36
Tangible Book Value Per Share
11.46188.83294.50
SEC Filings: 10-K · 10-Q